Skip to main content

NW London CLRN Primary Care Meeting

One of the organisations I work with is the North-West London Comprehensive Local Research Network (CLRN). The North-West CLRN is one of 25 CLRNs across England which form part of the NIHR Comprehensive Clinical Research Network (CCRN). The CCRN provides support for clinical trials and other well designed studies in all areas of disease and clinical need. A key role for the CLRN is providing infrastructure support for studies on the NIHR Portfolio. Part of this infrastructure support is in primary care. On October 7th 2009, the CLRN held a meeting with some of the local GPs and other primary care staff who collaborate with the CLRN.

One of the key points arising from the meeting was the need to get more NIHR portfolio studies active in primary care in NW London. IT issues were also discussed, particularly the need for expertise to run queries on GP Electronic Patient Record Systems such as EMIS and Vision. The need to continue reimbursement of practice expenses and also to offer additional value to GPs through involvement in research design and planning, access to training etc was also discussed, as was the high administrative workload in processing invoices for service support costs from a large number of general practices. We also discussed the need to review current levels of Clinical Study Officer (CSO) provision and to increase this if warranted by a rising number of accruals. The need for high-level GP/academic input to overcome some of the blocks that can be present in primary care research by liaising with relevant senior staff in PCTs and practices was also raised.

We will take forward these points in future CLRN meetings and with the Primary Care Research Network for Greater London (PCRN-GL).


Popular posts from this blog

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.60 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What will Brexit mean for the NHS?

On the 29 March 2017, the Prime Minister of the UK Theresa May, formally notified the European Union (EU) Council President, Donald Tusk, of the UK’s intention to leave the EU. Theresa May’s letter to Donald Tusk triggers a two-year process during which the UK will have to negotiate both the terms of its exit from EU and the arrangements that will replace those we have had for over 40 years with the other member states of the EU. The consequences of the United Kingdom’s departure from the EU (commonly referred to as ‘Brexit’) will be wide-ranging and will affect all areas of UK’s society, including the National Health Service (NHS).

For the NHS, Brexit comes at a time when it faces many other major challenges. These include severe financial pressures, rising workload, increased waiting times for both primary care and specialist services, and shortages of health professionals in many key areas (such as in general practice and in emergency departments). The NHS also faces challenges fr…

Dr Demis Hassabis, Co-Founder and CEO of DeepMind, Speaks about AI in Healthcare

On 28 September 2017, I attended the Annual Institute of Global Health Innovation Lecture: Artificial General Intelligence and Healthcare, delivered by Dr Demis Hassabis, co-founder and CEO of Google DeepMind. Artificial intelligence is the science of making machines smart argued Dr Hassabis, so how can we make it improve the healthcare sector? Dr Hassabis then went on to describe the work that DeepMind was carrying out in healthcare in areas such as organising information, deep learning to support the reporting of medical images (such as scans and pathology slides), and biomedical science. Dr Hassabis also discussed the challenges of applying techniques such as reinforcement learning in healthcare. He concluded that artificial intelligence has great scope for improving healthcare; for example, by prioritising the tasks that clinicians had to carry out and by providing decision support aids for both patients and doctors. Dr Hassabis also discussed some of the ethical issues in using …